Login / Signup

An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark.

Richard F PollockGorden Muduma
Published in: Advances in therapy (2018)
Pharmacosmos A/S.
Keyphrases
  • iron deficiency
  • patients with inflammatory bowel disease